Stock listing
NASDAQ:RXDX Prometheus Biosciences Inc Stock
Follow Prometheus Biosciences Inc into a list and get an email when it puts out news.
Last close · NASDAQ:RXDX
$199.92 USD
Close on Jun 16, 2023 · No longer trades
- Lowest – highest close
- $16.51 – $199.92 USDSince Mar 12, 2021 · lowest Mar 29, 2021 · highest Jun 15, 2023
Delisted NASDAQ:RXDX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RXDX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Prometheus Biosciences Inc on 6ix
- Decks
- 1 deck · latest Dec 7, 2022
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (December 2022) | Technical | 32 slides | Dec 7, 2022 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Fred Hassan Other companies: Recursion Pharmaceuticals, Inc. (Director · Since Oct 31, 2026); EyePoint, Inc. (Director · Since at least Sep 3, 2024); Cocrystal Pharma, Inc. (Director · Since at least Apr 20, 2023); BridgeBio Pharma, Inc. (Director · Since at least Aug 17, 2021); Precigen, Inc. (Director · Since at least Jun 30, 2016); Time Warner Inc (Director · Jun 1, 2016 – Jun 14, 2018 · Past); Amgen Inc. (Director · Jul 28, 2015 – May 5, 2020 · Past) | Director · May 14, 2021 – Jun 16, 2023 · Past |
| Mark C McKenna Other companies: Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Jul 16, 2024); Spyre Therapeutics, Inc. (Director · Since at least Feb 1, 2024); Apogee Therapeutics, Inc. (Director · Since at least Aug 17, 2023); Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Bausch Health Companies Inc. (President, Salix · Aug 2, 2018 – Aug 19, 2019 · Past) | Chairman, President and CEO, Director · Mar 11, 2021 – Jun 16, 2023 · Past |
Log in to ask 6ix AI your own questions about Prometheus Biosciences Inc.